UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

~~PURSUANT~~Pursuant TOto ~~SECTION~~Section 13 ORor 15(d) OFof ~~THE~~the

~~SECURITIES~~Securities ~~EXCHANGE~~Exchange ~~ACT~~Act OFof 1934

Date of Report (Date of earliest event reported): June 1622, 2026

INVO FERTILITY, INC.

(Exact name of registrant as specified in its charter)

Nevada		001-39701		20-4036208
(State or other jurisdiction of incorporation)		(Commission File Number)		(~~IRS~~I.R.S. Employer Identification No.)

5582 Broadcast Court

Sarasota, ~~Florida~~FL 34240

(Address of principal executive offices, including zip code)

(~~Zip Code~~978) 878-9505

(Registrant’s telephone number, including area code~~: (978~~) ~~878-9505~~

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol	Name of Each Exchange on Which Registered
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.0001 par value	IVF	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (~~CFR~~ §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (~~CFR~~ §240.12b-2 of this chapter). ~~Emerging growth company ☐~~

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 72.0102. ~~Regulation~~Results FDof ~~Disclosure~~Operations and Financial Condition.

~~INVO~~On June 22, 2026, INVO Fertility, Inc. (the “Company”), isissued ~~furnishing~~ a ~~copy~~press ofrelease anannouncing ~~investor~~financial ~~presentation~~results ~~(the~~for ~~“Presentation”) that~~ the quarter ~~Company~~ended ~~intends~~March ~~to use~~31, ~~in whole or in part, during the Company’s presentation at the Planet MicroCap Conference on June 17,~~ 2026. The ~~Presentation~~text ~~addresses the Company’s current and long-term operations, performance and industry conditions. On June 16, 2026, the Company posted a copy~~ of the ~~Presentation~~press torelease ~~the~~is ~~“Investors”~~furnished ~~portion~~as ofExhibit ~~its website (www~~99.~~invofertility.com).~~1 ~~These slides are attached~~ to this ~~Current~~current ~~Report on Form 8-K as Exhibit 99~~report.1.

The information ~~under~~in this Item 72.~~01,~~02 ~~including~~and Exhibit 99.1 hereto, ~~is being furnished and~~ shall not be deemed “filed” for the purposes of or otherwise subject to the liabilities under Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),. orUnless ~~otherwise subject to the liabilities~~expressly ~~of that section, nor shall it be deemed~~ incorporated byinto ~~reference~~a infiling ~~any~~of ~~filing~~the Company under the Securities Act of 1933, as amended, or the Exchange Act, ~~except~~the asinformation ~~expressly set forth by specific reference~~ contained in ~~such~~this aItem ~~filing~~2.02 ~~The~~and ~~Company undertakes no obligation to update, supplement or amend the materials attached hereto as~~ Exhibit 99.1. Inhereto ~~addition,~~shall ~~Exhibit~~not ~~99.1~~be ~~furnished~~incorporated ~~herewith~~by ~~contains~~reference ~~statements~~into ~~intended~~any ~~as “forward-looking~~Company ~~statements”~~filing, ~~that~~whether ~~are~~made ~~subject~~before toor after the ~~cautionary~~date ~~language~~hereof, ~~about~~regardless ~~forward-looking~~of ~~statements~~any ~~set~~general ~~forth~~incorporation language in such ~~exhibit~~ filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description
Exhibit No.		Description
99.1		~~INVO~~Press ~~Fertility~~Release ~~Corporate~~dated ~~Presentation~~June 22, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).)

~~SIGNATURE~~-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 16, 2026

Date: June 22, 2026	INVO FERTILITY, INC.

	/s/ Steven Shum
	Steven Shum
	Chief Executive Officer

~~INVO FERTILITY, INC. By: /s/ Steven Shum Steven Shum Chief Executive Officer~~-3-

Filing Compare · INVO Fertility, Inc.